Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
06/2005
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908901 Hepatitis C inhibitor peptide analogs
06/16/2005WO2005054176A1 Peroxisome proliferator activated receptor modulators
06/16/2005WO2005053685A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
06/16/2005WO2004056750A8 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors
06/16/2005US20050131068 Therapy for lipid disorders; dyslipidemia; insulin resistance; antidiabetic agents; 4-(2-(((2,6-dichlorophenyl)methyl)thio)ethyl) amino)-2-oxoethoxxy methoxybenzenepropanoic acid
06/16/2005CA2548129A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
06/16/2005CA2547212A1 Peroxisome proliferator activated receptor modulators
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539677A2 Succinic acid semi-amides as anti-corrosives agents
06/15/2005EP1539675A2 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1237872A4 Compounds and compositions for delivering active agents
06/15/2005EP1064252B1 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
06/15/2005EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones
06/15/2005CN1206226C Method for preparing effective anti-virus cyclopropane derivative and intermediate used thereof
06/15/2005CN1206207C Preparation method of cyanophthaofluoroaniline
06/15/2005CN1205994C Pulmonary delivery of active agents
06/14/2005US6906104 Aminediols for the treatment of Alzheimer's disease
06/14/2005US6906030 Carbon-substituted diketopiperazine delivery systems
06/14/2005CA2150229C Nitric esters having a pharmacological activity and process for their preparation
06/14/2005CA2121917C Fungicides for the control of take-all disease of plants
06/09/2005WO2005051894A1 Novel salicylic anilides
06/09/2005WO2005051893A2 Vitamin d receptor modulators
06/09/2005WO2005051892A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines
06/09/2005WO2004101602A3 Hepatitis c inhibitor peptide analogs
06/09/2005US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
06/09/2005US20050123481 Radio-opaque polymeric biomaterials
06/09/2005CA2547281A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines
06/09/2005CA2545023A1 Novel salicylic anilides
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1205202C N-carbanilides used as pesticides
06/08/2005CN1205177C Process for producing depsipeptide derivs, and noval intermidiates therefor
06/07/2005US6903094 As analgesic
06/07/2005US6903092 Naphthamide neurokinin antagonists for use as medicaments
06/07/2005CA2051693C Allosteric hemoglobin modifiers
06/02/2005WO2005048737A1 Bitter seasoning
06/02/2005US20050119487 Naphthol derivative and charge control agent comprising the same
06/02/2005US20050119474 Geranyl compounds
06/02/2005US20050118248 fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ionic groups
06/02/2005US20050118131 N-(hydroxy-sulfato or phosphato-alkanoyl) fatty amines; excellent permeability barrier, improved water solubility; skin has improved moisture retention
06/01/2005EP1534669A1 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
06/01/2005EP1534664A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
06/01/2005EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
06/01/2005CN1622934A Short-acting sedative hypnotic agents for anesthesia and sedation
06/01/2005CN1622832A Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
06/01/2005CN1204262C Method for producing optically active amines
06/01/2005CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics
05/2005
05/31/2005US6900354 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
05/31/2005US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005US20050113453 Development of new selective estrogen receptor modulators
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113400 Novel benzophenone derivatives or salts thereof
05/26/2005US20050113364 Reacting 3-ethoxy-4-hydroxyphenylacetic acid propyl ester with a compound of the formula X CH2C( .dbd. O)N(CH2CH3)2, wherein X is a leaving group, in the presence of a base to form [4-[(N,N-diethylcarbamoyl)methoxy]-3-ethoxyphenyl]acetic acid propyl ester
05/26/2005US20050113362 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/25/2005EP1532106A1 Photostable cationic organic sunscreen compounds and compositions obtained therefrom
05/25/2005DE10349497A1 N-substituierte Pyrazolylcarboxanilide N-substituted pyrazolylcarboxanilides
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1620427A Pseudo-nervonic amide and cosmetics composition containing the same
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620423A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1620422A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1620421A Substituted alkyl diamine
05/24/2005US6897338 Treating biomass containing a polyhydroxyalkanoate to form an alkenoic acid
05/24/2005US6897220 Antiproliferative agents
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005WO2005044786A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
05/19/2005WO2005044191A2 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005016868A3 Matrix metalloproteinase inhibitors
05/19/2005WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005US20050107619 Z-substituted acrylamides, methods for production thereof and agents comprising the same
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/19/2005CA2545100A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
05/18/2005CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
05/18/2005CN1617851A Naphthol derivative and charge control agent comprising the same
05/17/2005US6894185 Substituted chiral allosteric hemoglobin modifiers
05/17/2005US6894172 Stereospecific catalysts comprising chelate compounds used for alkylation, reduction, cyclization, hydrogenation, amination, epoxidation, aldol or Michael condensations
05/17/2005US6894036 4-dedimethylaminotetracycline derivatives
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042480A2 N-substituted pyrazolyl carboxanilides
05/12/2005WO2005042472A2 Hydroxypropyl amides for the treatment of alzheimer’s disease
05/12/2005WO2005041946A1 Development of new selective estrogen receptor modulators
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005000803A8 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 157